![HilleVax Inc](/common/images/company/N_HLVX.png)
HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norov... HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection. 詳細を表示
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.1183 | -6.16145833333 | 1.92 | 1.94 | 1.67 | 264169 | 1.78643016 | CS |
4 | -0.1283 | -6.64766839378 | 1.93 | 2.036 | 1.67 | 169933 | 1.87036785 | CS |
12 | -0.0383 | -2.08152173913 | 1.84 | 2.15 | 1.67 | 262362 | 1.94699697 | CS |
26 | 0.1017 | 5.98235294118 | 1.7 | 2.15 | 1.64 | 248903 | 1.89072878 | CS |
52 | -12.8983 | -87.743537415 | 14.7 | 20.22 | 1.55 | 424239 | 3.77396446 | CS |
156 | -16.9583 | -90.3960554371 | 18.76 | 24.42 | 1.55 | 215725 | 7.09891168 | CS |
260 | -16.9583 | -90.3960554371 | 18.76 | 24.42 | 1.55 | 215725 | 7.09891168 | CS |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約